Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Cancer Biomarkers Identified Using Chromatrap® ChIP Assay

Published: Wednesday, September 12, 2012
Last Updated: Wednesday, September 12, 2012
Bookmark and Share
New approach to ChIP assays - Developed by Porvair Filtration Group.

As the incidence of cancer is expected to affect around 26 million by 2030, clinicians and scientists strive to understand its initiation and proliferation at a molecular level.

Epigenetic research is key to these studies, examining heritable changes in gene expression that occur without the alteration in DNA sequence, and cancer.

Chromatin immunoprecipitation (ChIP) assays are an essential tool in epigenetic research. A new approach to ChIP assays called Chromatrap® has been developed by Porvair Filtration Group.

Based on Porvair’s proprietary BioVyon™ porous plastic materials and taking advantage of its long experience in separation techniques, Chromatrap® ChIP assay kits have particular relevance to identifying cancer biomarkers.

The development of Chromatrap®, a highly sensitive and specific ChIP Assay Kit, is the result of extensive research into chemically functionalizing the internal surfaces of micro porous High Density Polyethylene (HDPE).

Success has meant it is now being adopted in a growing number of new biochemical applications like Chromatrap®.

This novel Chromatrap® technology has been packaged in kits with easy to use spin columns for single use experiments or 96-well high throughput plates, ideal for multiple assays associated with drug screening.

The benefits are far reaching: improved purity with low signal to noise ratios and increased DNA recovery from small cell numbers.

Chromatrap® 96-well high throughput plates will be showcased at Genomics Research Europe, Frankfurt, Germany, 4th-5th September 2012.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
New Centre Offers Ultra-Speed Protein Analysis
UW-Madison researchers to establish development centre for next-gen protein measurement technologies.
Drug Candidates Reduce Abnormal Protein Production
New drug candidates improve cell ability to catch miss-folded proteins that could cause deadly diseases.
Supercomputing and Drug Discovery
New biotech company uses supercomputer simulations to speed up drug discovery and biotech molecule development.
Preventing Breast Cancer with Hops
Study of hops extract suggests prevention of breast cancer through chemical pathway activation.
Treatment Advancement for Gaucher and Parkinson's Diseases
NIH scientists identify molecule that may act as a possible treatment of neurological diseases.
Biomunex Confirms Optimal Properties and Activity of BiXAb® Antibodies
Biomunex‘s Plug-and-Play bispecific antibodies demonstrated excellent in vitro properties and in vivo activity positively differentiating their BiXAb platform from competing formats.
Liquid Biopsy Predicts Colon Cancer Recurrence
Scientists have used a genetic test that spots bits of cancer-related DNA circulating in the blood to accurately predict the likelihood of the disease’s return in some — but not all — of a small group of patients with early-stage colon cancer.
New Treatment for Rare Blood Cancers
Drug called midostaurin showed promise in an international clinical trial led by a Stanford physician.
Biomarker for Parkinson's Disease Found in Urine Samples
Protein identified as Parkinson's biomarker sourced from patient's stored frozen urine samples.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!